news

  • Home
  • News & Media
Press releases
Topline POEM Study Results Position EMP16 as a Promising Oral Weight-Loss Maintenance Therapy
Press releases
Empros Pharma Launches Pilot Trial Ahead of EMP16 Phase III Program
Press releases
Empros phase 2b obesity trial enrollment complete in only one month..
Blog
A short overview of the chronic disease obesity
Press releases
Empros pharma doses first patients in large scale clinical study of anti-obesity drug EMP-16